Medication info
Myungmoon Ranitidine Tablet 10 mg

Myungmoon Ranitidine Tablet 10 mg

Prescription medicationTabletOral
Ingredient · strength
Lafutidine›10mg / 1 tablet
Manufacturer / importer
Myungmoon Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201402431 · Approved 2014.05.29 · Insurance code 649806590

Summary

Main use
Treatment of gastrointestinal disorders (ulcers, gastritis, etc.), preanesthetic medication, combination therapy for Helicobacter pylori
Who takes it
Adults
Adult dose
1. Short-term treatment of gastric ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and before bedtime. In clinical trials involving treatment for up to 8 weeks, most ulcers healed within 8 weeks, although the healing period may occasionally vary among patients. 2. Short-term treatment of duodenal ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and before bedtime. In clinical trials involving treatment for up to 6 weeks, most ulcers healed within 6 weeks, although the healing period may occasionally vary among patients. 3. Improvement of gastric mucosal lesions in acute gastritis and chronic gastritis: The usual dose is 10mg of lafutidine orally once daily before bedtime. In clinical trials involving treatment for up to 2 weeks, most lesions healed within 2 weeks, although the healing period may occasionally vary among patients. 4. Concomitant antibiotic therapy for patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication for anesthesia: The usual dose is 10mg of lafutidine orally twice (before bedtime on the day before surgery and 2 hours before administration of anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer 10mg of lafutidine orally twice.

Ingredients

Manufacturer
Myungmoon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (ulcers, gastritis, etc.), preanesthetic medication, combination therapy for Helicobacter pylori

  • Gastric ulcer
  • duodenal ulcer
  • acute gastritis
  • chronic gastritis with gastric mucosal lesions
  • peptic ulcer
  • gastroesophageal reflux disease
View approved original text

This medication is effective in treating gastric ulcers and duodenal ulcers. It also helps improve gastric mucosal damage in acute and chronic gastritis. For patients with peptic ulcers due to Helicobacter pylori infection, it enhances treatment efficacy when used in combination with antibiotics. It can be used as pre-medication before surgery or procedures. Finally, it is used to treat gastroesophageal reflux disease, alleviating symptoms. Overall, this drug is used for the treatment and symptom improvement of various gastrointestinal diseases.

How to take

Adult dose

1. Short-term treatment of gastric ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and before bedtime. In clinical trials involving treatment for up to 8 weeks, most ulcers healed within 8 weeks, although the healing period may occasionally vary among patients. 2. Short-term treatment of duodenal ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and before bedtime. In clinical trials involving treatment for up to 6 weeks, most ulcers healed within 6 weeks, although the healing period may occasionally vary among patients. 3. Improvement of gastric mucosal lesions in acute gastritis and chronic gastritis: The usual dose is 10mg of lafutidine orally once daily before bedtime. In clinical trials involving treatment for up to 2 weeks, most lesions healed within 2 weeks, although the healing period may occasionally vary among patients. 4. Concomitant antibiotic therapy for patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication for anesthesia: The usual dose is 10mg of lafutidine orally twice (before bedtime on the day before surgery and 2 hours before administration of anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer 10mg of lafutidine orally twice.

Precautions

This drug should not be used in patients with allergies to any of its components. It contains lactose; therefore, patients with genetically determined lactose intolerance should not take it. Patients with a history of hypersensitivity to this medication, renal or liver dysfunction, patients undergoing dialysis, and the elderly need special caution when using this drug. This drug may rarely cause severe allergic reactions; if symptoms such as pallor, drop in blood pressure, or difficulty breathing occurs, stop taking it immediately and seek medical attention. Since it may affect liver function, regular liver function tests should be conducted, and the medication must be stopped if abnormalities are found. There may also be symptoms indicating reduced blood cell counts; if experiencing sore throat, lethargy, or fever, consult a doctor immediately. There have been cases of serious side effects such as skin rash, seizures, and heart issues among those who have taken similar medications, so report any unusual symptoms immediately. Various side effects have been reported involving the gastrointestinal tract, central nervous system, circulatory system, and hematologic system, so inform medical personnel if you notice changes in your body condition. Elderly individuals may have decreased bodily functions, so dosing and administration intervals should be carefully adjusted. Patients undergoing dialysis may accumulate the drug in their bodies; therefore, it should be started at a lower dose and increased gradually. Pregnant women or women who may become pregnant should only take this medication after consulting a doctor, and breastfeeding women should avoid it as it may be secreted into breast milk. Safety has not been established for children, so it is advisable not to use it for this population. This drug should be kept out of reach of children and stored in its original container for safety. Long-term use may mask symptoms of malignancy, so any unusual symptoms should lead to immediate testing. Regular blood tests, liver function tests, and kidney function tests are important to check health status during the use of this medication.

Side effects

  • Shock
  • symptoms of anaphylaxis
  • facial pallor
  • hypotension
  • generalized rash
  • dyspnea
  • hepatic dysfunction
  • jaundice
  • agranulocytosis
  • pharyngalgia
Show 82 more
  • generalized fatigue
  • fever
  • thrombocytopenia
  • aplastic anemia
  • seizures
  • interstitial nephritis
  • Stevens-Johnson syndrome
  • Reye's syndrome
  • rhabdomyolysis
  • heart block
  • reduced contraction
  • constipation
  • diarrhea
  • hard stool
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • headache
  • insomnia
  • drowsiness
  • reversible confusional state
  • hallucination
  • consciousness disturbance
  • dizziness
  • chills
  • heat sensation
  • facial flushing
  • leukocytosis
  • eosinophilia
  • leukopenia
  • erythrocytopenia
  • reduced hematocrit
  • elevated ALT (GPT)
  • elevated AST (GOT)
  • elevated Al-P
  • elevated γ-GTP
  • elevated T-Bil
  • elevated LDH
  • elevated TTT
  • abnormal urine protein
  • elevated BUN
  • elevated serum uric acid
  • elevated Cl
  • delayed delivery
  • elevated Na
  • reduced K
  • gynecomastia
  • edema
  • fatigue
  • glossitis
  • headache
  • chest pain
  • subdural hemorrhage
  • urticaria
  • skin rash
  • abdominal pain
  • dyspepsia
  • enteritis
  • gastric ulcer
  • erosive gastritis
  • duodenitis
  • bloating
  • rhinitis
  • upper respiratory infection
  • bronchopneumonia
  • tinea
  • carotid artery stenosis
  • cough
  • oral pharyngeal pain
  • pharyngeal discomfort
  • wet cough
  • fatigue
  • chest pain
  • limb pain
  • arthralgia
  • cervical pain
  • pruritus
  • acne
  • contusion
  • insomnia
  • non-alcoholic fatty liver disease

Not everyone experiences these, and they can vary from person to person.

Storage

This drug must be stored in a tightly sealed container to prevent exposure to air or moisture. It is advisable to maintain room temperature between 1 degree and 30 degrees Celsius. This will help preserve the drug's effectiveness for a longer time.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.